Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury.
about
Non-steroidal anti-inflammatory drug delays corneal wound healing by reducing production of 12-hydroxyheptadecatrienoic acid, a ligand for leukotriene B4 receptor 2.Pneumolysin induced mitochondrial dysfunction leads to release of mitochondrial DNA.Inhibition of 5-lipoxygenase alleviates graft-versus-host disease.Biological functions of 12()-hydroxyheptadecatrienoic acid as a ligand of leukotriene B receptor 2Leukotriene B4 promotes neovascularization and macrophage recruitment in murine wet-type AMD models
P2860
Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 05 October 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury.
@en
Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury.
@nl
type
label
Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury.
@en
Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury.
@nl
prefLabel
Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury.
@en
Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury.
@nl
P2093
P2860
P356
P1433
P1476
Leukotriene B4 receptor type 2 protects against pneumolysin-dependent acute lung injury
@en
P2093
Airi Jo-Watanabe
Ayako Ishimori
Hideo Shindou
Jian-Dong Li
Kazuko Saeki
Makoto Murakami
Misako Shigematsu
Sumio Hoka
Takeshi Harayama
P2860
P2888
P356
10.1038/SREP34560
P407
P577
2016-10-05T00:00:00Z